Most recently, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to a big range of endogenous opioids. Compared with most opioid receptors, this receptor acts as a scavenger and won't https://isaacp121dgh2.blogginaway.com/profile